Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 01, 2019

SELL
$5.66 - $11.85 $151,359 - $316,892
-26,742 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$4.32 - $6.43 $115,525 - $171,951
26,742 New
26,742 $160,000
Q1 2019

May 15, 2019

SELL
$4.12 - $10.25 $123,727 - $307,817
-30,031 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$8.2 - $16.95 $246,254 - $509,025
30,031 New
30,031 $282,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $71.8M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.